Cargando…
Favorable outcome of COVID-19 in a young woman with severe Crohn’s disease on regular use of adalimumab and prednisone: a case report
COVID-19 is a viral disease caused by SARS-CoV-2 that compromises the host immune response in severe cases, promoting a hyperinflammation that results in acute lung injury and multiple organs failure. In this context, patients presenting with immune-related diseases, such as Crohn’s disease, affecte...
Autores principales: | Vechi, Hareton Teixeira, Maia, Lucas Rodrigues, Alves, Manoela do Monte, Rodrigues-Neto, João Firmino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto de Medicina Tropical
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748034/ https://www.ncbi.nlm.nih.gov/pubmed/33331521 http://dx.doi.org/10.1590/S1678-9946202062102 |
Ejemplares similares
-
Late acute pulmonary embolism after mild Coronavirus Disease 2019 (COVID-19): a case series
por: Vechi, Hareton Teixeira, et al.
Publicado: (2020) -
Nodular Pachymeningitis Associated With Relapsing Polychondritis and Crohn Disease Responsive to Adalimumab and Prednisone
por: Hutto, Spencer K., et al.
Publicado: (2021) -
Chronic cavitary pneumonia by Rhodococcus equi in a highly prevalent tuberculosis country: a diagnosis challenge
por: Vechi, Hareton Teixeira, et al.
Publicado: (2018) -
Adalimumab/prednisone: Mycobacterium chelonae infection: case report
Publicado: (2021) -
Adalimumab in Crohn’s disease
por: Van Assche, Gert, et al.
Publicado: (2007)